Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Alcon signs licensing agreement with GSK for cilomilast and expands alliance with Origenis

Oct. 17, 2008

Sirion presents pivotal uveitis data for Durezol

Oct. 17, 2008

New therapeutic agents for eye disorders imparted in recent Santen patent

Oct. 17, 2008

Sirion launches Durezol for postoperative ocular inflammation and pain

Oct. 16, 2008

Pfizer launches Macugen for age-related macular degeneration in Japan

Oct. 15, 2008

QLT initiates phase I trial of synthetic retinoid product QLT-091001

Oct. 10, 2008

Phase I trial of Inspire's INS-117548 for glaucoma begins

Oct. 10, 2008

Lux licenses from Isotechnika global rights to voclosporin in all ophthalmic indications

Oct. 9, 2008

pSivida reports 6-month interim readout of the human PK Iluvien study

Oct. 6, 2008

Potentia presents positive safety data in phase I POT-4 trial

Oct. 1, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...